Mirus Bio provides gene transfer methods to the pharmaceutical business. The company focuses on the discovery and development of novel nucleic acid-based technologies, such as a proprietary RNAi (Ribonucleic Acid Interference) delivery platform, providing life scientists with advanced instruments for gene expression, biotherapeutic protein